News | June 27, 2007

ICDs Improve Survival Rates Reports Study

June 28, 2007 - Patients who receive implantable cardiac defibrillators (ICD) have a better survival rate than their counterparts who do not undergo ICD implantation, according to a study by Canadian researchers published in the June 26th issue of the Journal of the American College of Cardiology (J Am Coll Cardiol 2007;49:2408-2415).

The study tracked 2,467 ICD recipients and their comorbidities for three years prior to implantation. The major factors that reduced survival in ICD recipients were age, previous heart failure and noncardiac comorbidities, according to the report. Mortality rates at one year were 7.8 percent and 14 percent at two years. Recipients 65 to 74 years had a higher hazard ratio, 2.05, compared to younger recipients. Nearly half (46.2 percent) of the recipients had previous heart failure, greatly increasing their risk of death by a hazard ratio of 2.33.
"Heart failure was a common condition in ICD recipients, and was the only cardiac condition that affected survival. Optimizing heart failure care in ICD recipients may improve future survival outcomes," said lead investigator, Douglas S. Lee, M.D., University Health Network, Toronto. "The presence of noncardiac comorbidities may contribute to patient selection for ICDs in the future."

For more information: www.acc.org/media/media_journals.htm

Related Content

Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Predictive Models May Help Determine Which Patients Benefit From ICDs
News | Implantable Cardioverter Defibrillator (ICD)| July 06, 2017
Two predictive models may help cardiologists decide which patients would most benefit from an implantable cardioverter...
Medtronic Reactive ATP Therapy Slows Progression of Atrial Fibrillation in Real-World Population
News | Atrial Fibrillation| July 03, 2017
Medtronic recently announced that its Reactive ATP therapy slows the progression of atrial fibrillation (AF) in...
Sponsored Content | Videos | Cardiovascular Ultrasound| June 29, 2017
Leyla Elif Sade, M.D., MESC, professor of cardiology at Başkent University, Ankara, Turkey, discusses use of echo for
Biosense webster multielectrode balloon RF ablation catheter

The Biosense Webster multi-electrode balloon RF ablation catheter. Each electrode can have varied power settings to avoid damage to underlying tissues like the esophagus. 

Feature | EP Lab| June 22, 2017 | Dave Fornell
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve...
Pacemakers and Other Cardiac Devices Can Help Solve Forensic Cases
News | Pacemakers| June 20, 2017
Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented at the European...
Sponsored Content | Videos | Implantable Cardioverter Defibrillator (ICD)| June 01, 2017
Lucas Boersma, M.D., Ph.D., FESC, St.
Sponsored Content | Videos | Leads Implantable Devices| May 25, 2017
Bruce Wilkoff, M.D., director of cardiac pacing and tachyarrhythmia devices at Cleveland Clinic, discusses advancemen
Overlay Init